May 3, 2024
JAMA Health Forum Editor John Ayanian, MD, MPP, speaks with
Kelsey M. Owsley, PhD, of the University of Arkansas, and Sayeh
Nikay, PhD, MPH, of the University of Minnesota, about how the 340B
drug discount program influences the services offered by public and
nonprofit hospitals. They also discuss new state policies and
proposed federal policies to promote greater transparency and
accountability in the 340B program.
Related Content: